SMURF2 and cancer: In fact, the reduction of SMURF2 levels by siRNA or inhibitors leads to a decrease not only in cell survival/proliferation but also in migration and invasive abilities of cancer cells (David et al., 2014; Jin et al., 2009; Klupp et al., 2019).